Motor Neurone Disease Trial, Recruiting (NCT06819124)

Motor Neurone Disease Trial, Recruiting NCT06819124 Sponsor: Penn State University Condition: Motor Neurone Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06819124 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Motor Neurone Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with ALS (also called PALS):

You have been officially diagnosed with ALS (amyotrophic lateral sclerosis) based on standard diagnostic guidelines
You have no history of other neurological conditions, such as a stroke
You do not have cognitive impairment (thinking or memory problems), as checked by a brief telephone-based assessment
You have noticeable changes to your speech as measured by a standard ALS rating scale
You are able to say at least single words
You are a native speaker of American English

For caregivers:

You are a caregiver of someone with ALS who is participating in this trial
You are a native speaker of American English

Who may not be able to join:

There are no additional exclusion criteria listed — if you meet all of the inclusion criteria above, you would be eligible to enroll

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jimin Lee, Ph.D., Penn State University

Phone: 814-867-3373

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06819124

Sponsor: Penn State University

Phase: Not Applicable

Status: Recruiting

Condition: Motor Neurone Disease

Trial contact: 814-867-3373

More information: https://clinicaltrials.gov/study/NCT06819124

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people with ALS (also called PALS):

You have been officially diagnosed with ALS (amyotrophic lateral sclerosis) based on standard diagnostic guidelines
You have no history of other neurological conditions, such as a stroke
You do not have cognitive impairment (thinking or memory problems), as checked by a brief telephone-based assessment
You have noticeable changes to your speech as measured by a standard ALS rating scale
You are able to say at least single words
You are a native speaker of American English

For caregivers:

You are a caregiver of someone with ALS who is participating in this trial
You are a native speaker of American English

Who may not be able to join:

There are no additional exclusion criteria listed — if you meet all of the inclusion criteria above, you would be eligible to enroll

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Penn State University

Registry

ClinicalTrials.gov

Start date

22 January 2025

Est. completion

28 February 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Formant frequencies of speech sounds; Intelligibility of recorded speech; Syntactic properties; Pragmatic Properties; Duration of speech sounds

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov